# Circulate Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/circulate-health

- Industry: Healthcare
- Headquarters: Seattle, US
- Website: www.circulate.health
- Total disclosed funding: $12M
- Latest round: Seed (Jul 1, 2025)
- Investors on record: 3

## About

Circulate Health Inc., based in the US, offers innovative Therapeutic Plasma Exchange (TPE) services, targeting age-related health challenges through evidence-based medical treatments designed to enhance patient well-being.Founded in 2021 and headquartered in Seattle, US, Circulate Health Inc. specializes in Therapeutic Plasma Exchange (TPE) to address age-related health issues. The company has completed one deal, with its latest funding round being a Seed round in July 2025, which raised USD 12.00 mn led by Khosla Ventures, with participation from CSC Upshot Ventures and Seaside Ventures. This funding supports their growth strategy without any known pivots or changes in business operations.Circulate Health specializes in providing Therapeutic Plasma Exchange (TPE), an evidence-based medical treatment designed to remove inflammatory and age-related substances from the bloodstream. This innovative therapy addresses the significant health challenges associated with aging, as age-related diseases contribute to over 90% of annual healthcare expenditures in the United States. TPE is structured to deliver rapid therapeutic benefits, particularly in managing age-related diseases and autoimmune conditions, thereby enhancing patients' overall well-being. Circulate's services primarily target clinics and healthcare providers, enabling them to offer fully managed TPE treatments without the need for substantial investments in technology or staffing. The geographical markets for these services span major metropolitan areas across the United States, including California, Texas, Florida, and New York, indicating a broad reach to various patient demographics.Circulate Health generates revenue through its comprehensive TPE solution, which is provided to clinics and healthcare facilities on a partnership basis. The transaction structure is primarily B2B, with clinics leveraging Circulate's expertise and proprietary technology to deliver TPE treatments to their patients. While specific pricing plans for the services are not disclosed, the business model typically encompasses service fees that clinics incur for utilizing Circulate's TPE system and protocols. This arrangement allows clinics to offer advanced treatment options without the capital expenditure associated with in-house technology. The revenue model is designed to create mutually beneficial partnerships, enhancing patient care while driving growth in Circulate’s client base.In July 2025, Circulate Health raised USD 12.00 mn in Seed funding to support the expansion of its market reach and further development of its services. The company plans to enhance its TPE offerings while targeting expansion into additional geographic regions beyond its current markets of California, Texas, Florida, and New York. The funding will be utilized strategically to facilitate these initiatives.

## Funding rounds

- Seed, Jul 1, 2025, $12M — Khosla Ventures, CSC Upshot Ventures, Seaside Ventures

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Seed
- CSC Upshot Ventures (https://capitalatlas.ai/funds/csc-upshot-ventures) — Seed
- Seaside Ventures (https://capitalatlas.ai/funds/seaside-ventures) — Seed